- Home
- BCRX vs HOG Comparison
BCRX vs HOG Comparison
Compare BCRX & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | HOG |
|---|---|---|
| Founded | 1986 | 1903 |
| Country | United States | United States |
| Employees | N/A | 6400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BCRX | HOG |
|---|---|---|
| Price | $8.26 | $23.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | $20.82 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 4.2M | 2.8M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $25,186,000.00 | ★ $4,473,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.55 | $3.79 |
| P/E Ratio | ★ N/A | $106.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.00 | $17.09 |
| 52 Week High | $11.31 | $31.25 |
Technical Indicators
Market Signals| Indicator | BCRX | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 50.39 |
| Support Level | $7.94 | $22.34 |
| Resistance Level | $8.68 | $24.83 |
| Average True Range (ATR) | 0.46 | 1.26 |
| MACD | -0.08 | -0.31 |
| Stochastic Oscillator | 23.34 | 29.96 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.